The second Team Haemophilia Education Meeting, 2016, Frankfurt, Germany.

about

The second Team Haemophilia Education Meeting, 2016, Frankfurt, Germany.

Item

http://www.wikidata.org/entity/Q45232152

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

The second Team Haemophilia Education Meeting, 2016, Frankfurt, Germany.

@en

The second Team Haemophilia Education Meeting, 2016, Frankfurt, Germany.

@nl

type

Item

label

The second Team Haemophilia Education Meeting, 2016, Frankfurt, Germany.

@en

The second Team Haemophilia Education Meeting, 2016, Frankfurt, Germany.

@nl

prefLabel

The second Team Haemophilia Education Meeting, 2016, Frankfurt, Germany.

@en

The second Team Haemophilia Education Meeting, 2016, Frankfurt, Germany.

@nl

P1476

The second Team Haemophilia Education Meeting, 2016, Frankfurt, Germany.

@en

P2093

Andrea S Doria

http://www.w3.org/2001/XMLSchema#string

Anna Farrell

http://www.w3.org/2001/XMLSchema#string

Athina Dettoraki

http://www.w3.org/2001/XMLSchema#string

Daniel Hart

http://www.w3.org/2001/XMLSchema#string

David Perry

http://www.w3.org/2001/XMLSchema#string

Edward Laane

http://www.w3.org/2001/XMLSchema#string

Erik Berntorp

http://www.w3.org/2001/XMLSchema#string

Hervé Chambost

http://www.w3.org/2001/XMLSchema#string

Lochana Nanayakkara

http://www.w3.org/2001/XMLSchema#string

Lorenzo Mantovani

http://www.w3.org/2001/XMLSchema#string

P2860

Somatic mosaicism in hemophilia A: a fairly common event.

A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey.

Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation.

Phase 3 study of recombinant factor VIII Fc fusion protein in severe hemophilia A.

Implications of coagulation factor VIII and IX pharmacokinetics in the prophylactic treatment of haemophilia.

The benefits of exercise for patients with haemophilia and recommendations for safe and effective physical activity.

Applicability of the European Society of Cardiology guidelines on management of acute coronary syndromes to people with haemophilia - an assessment by the ADVANCE Working Group.

The effectiveness of exercise interventions to prevent sports injuries: a systematic review and meta-analysis of randomised controlled trials.

Changing paradigm of prophylaxis with longer acting factor concentrates.

Prenatal diagnosis in haemophilia A: experience of the genetic diagnostic laboratory.

P304

1-15

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/EJH.12828

http://www.w3.org/2001/XMLSchema#string

P478

98 Suppl 85

http://www.w3.org/2001/XMLSchema#string

P50

P577

2017-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28101938

http://www.w3.org/2001/XMLSchema#string

P921

hemophilia

A' Ghearmailt